Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Oil for Adults with ADHD
NCT05219370Phase 2Terminated
- Sponsor
- BRLEV AGRICULTURAL CROPS LTD
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, cannabigerol in attention deficit hyperactivity disorder (ADHD), sponsored by BRLEV AGRICULTURAL CROPS LTD. Started Jul 2022; status: terminated.
02
Drugs
cannabidiolcannabigerol
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05219370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219370.